Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

KalVista Pharmaceuticals (KALV) Other Non Operating Income (2016 - 2025)

Historic Other Non Operating Income for KalVista Pharmaceuticals (KALV) over the last 9 years, with Q2 2025 value amounting to $18000.0.

  • KalVista Pharmaceuticals' Other Non Operating Income fell 9925.99% to $18000.0 in Q2 2025 from the same period last year, while for Apr 2025 it was $6.3 million, marking a year-over-year decrease of 3772.12%. This contributed to the annual value of $4.8 million for FY2025, which is 5073.21% down from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Other Non Operating Income of $18000.0 as of Q2 2025, which was down 9925.99% from $1.6 million recorded in Q3 2024.
  • KalVista Pharmaceuticals' 5-year Other Non Operating Income high stood at $2.4 million for Q2 2024, and its period low was $18000.0 during Q2 2025.